evitria AG Revenue and Competitors
Estimated Revenue & Valuation
- evitria AG's estimated annual revenue is currently $5.4M per year.
- evitria AG's estimated revenue per employee is $155,000
Employee Data
- evitria AG has 35 Employees.
- evitria AG grew their employee count by -8% last year.
evitria AG's People
| Name | Title | Email/Phone |
|---|
evitria AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46850M | 145000 | 16% | $20.2B | $539B |
What Is evitria AG?
evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 50,000 transfections performed and more than 9,000 antibodies expressed and purified for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland) and affordable prices. Transfections are made with serum-free, animal-component free reagents at a monthly capacity of up to 500 liters. You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
keywords:N/A
N/A
Total Funding
35
Number of Employees
$5.4M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
evitria AG News
... the drug delivery expert Develco Pharma AG, which is based in Switzerland and Germany, and the Swiss company evitria AG, a global market...
evitria Licenses mAbsolve Gene Silencing Technology. March 15, 2022. BioPharm International Editors ... Source: evitria AG. Related Content:.
Other Companies in Schlieren
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 36 | N/A | N/A |
#2 | $5.9M | 38 | 9% | N/A |
#3 | $6.7M | 43 | 26% | N/A |
#4 | $5.1M | 44 | -19% | N/A |
#5 | $7M | 45 | 29% | N/A |